ABBVVSSGRX• 28 Days (Normalized)
ABBV vs SGRX (AbbVie Inc. vs SANGRIX INC.)
Showing Closing Date Range from Sep 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABBV Performance $271.36
+8.15%
AbbVie Inc.
Normalized Baseline0.00%
SGRX Performance $0.76
-54.04%
SANGRIX INC.
Normalized Baseline0.00%
Alpha Spread Margin ABBV LEADS
+62.19 pts
ABBV outperforming by 62.19 percentage points
ABBVSGRX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABBV SGRX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | ABBV Price | ABBV Gain (%) | SGRX Price | SGRX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $271.36 | +8.15% | $0.76 | -54.04% | +62.19% |
| Oct 06, 2026 | $266.69 | +6.29% | $0.76 | -54.22% | +60.51% |
| Oct 05, 2026 | $265.76 | +5.92% | $1.12 | -32.53% | +38.45% |
| Oct 02, 2026 | $262.82 | +4.75% | $1.26 | -24.10% | +28.85% |
| Oct 01, 2026 | $259.93 | +3.59% | $1.39 | -16.27% | +19.86% |
| Sep 30, 2026 | $261.59 | +4.26% | $1.59 | -4.22% | +8.48% |
| Sep 29, 2026 | $263.29 | +4.93% | $1.51 | -9.04% | +13.97% |
| Sep 28, 2026 | $266.28 | +6.13% | $1.56 | -6.02% | +12.15% |
| Sep 25, 2026 | $264.34 | +5.35% | $1.44 | -13.25% | +18.60% |
| Sep 24, 2026 | $- | $1.56 | -6.02% | - | |
| Sep 23, 2026 | $265.08 | +5.65% | $1.59 | -4.22% | +9.87% |
| Sep 22, 2026 | $265.21 | +5.70% | $1.69 | +1.81% | +3.89% |
| Sep 21, 2026 | $264.48 | +5.41% | $1.79 | +7.83% | -2.42% |
| Sep 18, 2026 | $263.96 | +5.20% | $1.75 | +5.42% | -0.22% |
| Sep 17, 2026 | $264.02 | +5.22% | $1.62 | -2.35% | +7.57% |
Page 1 of 2